Karen M. Black

Vice President Compliance & Product Development
Precision BioLogic Inc.
Dartmouth, Nova Scotia, Canada

Presentation(s):

• PB1147 - Effect of high-dose direct anticoagulant drugs and DOAC-Remove on lupus anticoagulant detection by a hexagonal phase phospholipid assay

  Tuesday, June 27, 2023
  18:30 – 19:30 ET